Dr. Edwin Lee
Endocrinologist & Clinical Researcher
Published the only peer-reviewed human BPC-157 clinical trial. Dr. Edwin Lee is a board-certified endocrinologist (FACE) and co-founder of the Clinical Peptide Society. His 2021 study injected 4mg BPC-157 directly into knee joints; 7 out of 12 patients reported pain relief lasting 6+ months from that single injection. The route matters: intra-articular, not subcutaneous. An assistant professor at UCF, Lee bridges the gap between community peptide use and actual clinical evidence.
Dr. Edwin Lee published the study everyone in the BPC-157 community references but few have actually read. His 2021 paper in Alternative Therapies is the only peer-reviewed human BPC-157 clinical trial to date. Twelve patients received a single intra-articular injection of 4mg BPC-157 for knee pain; 7 of them reported relief lasting 6+ months.
The route matters more than the dose here. Intra-articular injection (directly into the knee joint) is a physician-performed procedure, not comparable to subcutaneous self-injection protocols. The 4mg dose is also 8-16x higher than typical subcutaneous BPC-157 dosing (250-500mcg). A board-certified endocrinologist (FACE) and co-founder of the Clinical Peptide Society, Lee is an assistant professor at UCF.
One Tier 1 protocol is tracked on this page, sourced from the published paper (PubMed 34324435). Small sample size (12 patients in the BPC-157-only arm) means more research is needed, but this remains the strongest formal evidence for BPC-157 in humans.
Protocols by Dr.
2 disclosed protocols with verified dosing details.
Dr. Edwin Lee's BPC-157 Knee Protocol (Clinical Trial)
The only peer-reviewed human BPC-157 clinical trial, published in Alternative Therapies (2021). Dr. Edwin Lee injected 4mg BPC-157 directly into knee joints. Seven out of 12 patients reported pain relief lasting 6+ months from a single injection. The route is intra-articular, not subcutaneous. This is a physician-administered procedure, not a self-injection protocol.
via Dr. Edwin LeeDr. Edwin Lee's Longevity Protocol
Epithalon at 5mg daily for 10 days (2x/year) as his "#1 longevity peptide," plus TA-1 at a lower-than-standard 250mcg maintenance dose (1-2x/week, daily when sick). Discussed on the Dr. Hyman Show podcast.
via Dr. Edwin LeeSource Timeline
All verified sources where Dr. discussed peptide protocols.
Only peer-reviewed human BPC-157 clinical trial — 7/12 patients reported 6+ months relief from single injection
Frequently Asked Questions
Not medical advice. Talk to your provider before using any peptide.
Full disclaimer